Fred Eshelman
InvestorFounder at Eshelman Ventures, LLC
FoundedDignify TherapeuticsHyperion DefiInnocrin Pharmaceuticals HoldingsNeoantigenics
About
Founder of Eshelman Ventures who typically serves on the boards of portfolio companies. He previously founded and led Pharmaceutical Product Development (PPD, NASDAQ) as CEO and Executive Chairman before the company was sold to private equity.
Deals · 18
Hyperion DefiBoard seat
via Eshelman Ventures, LLC · filed Aug 2016 · $8M raise
Innocrin Pharmaceuticals HoldingsBoard seat
via Eshelman Ventures, LLC · filed Apr 2015 · $28.1M raise
NeoantigenicsBoard seat
via Eshelman Ventures, LLC · filed Feb 2015 · $3M raise
Incyclix BioSolo GP
via Eshelman Ventures, LLC · filed Aug 2025
Dignify TherapeuticsSolo GP
via Eshelman Ventures, LLC · filed Feb 2015 · $3.4M raise
Breakthru MedicineSolo GP
CarbonSolo GP
Cavalry BiosciencesSolo GP
Jupiter BioventuresSolo GP
Komo BiosciencesSolo GP
Med AditusSolo GP
Paradigm TherapeuticsSolo GP
Sapience TherapeuticsSolo GP
Wilmington Design Co.Solo GP
Aruna BioSolo GP
Auven TherapeuticsSolo GP
GenesisSolo GP
Attribution from SEC filings, press coverage, and firm rosters. Some rows are inferred. Not right? Tell us.